210 related articles for article (PubMed ID: 12191614)
1. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway.
Sasaki Y; Suzuki M; Hidaka H
Pharmacol Ther; 2002; 93(2-3):225-32. PubMed ID: 12191614
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor.
Ikenoya M; Hidaka H; Hosoya T; Suzuki M; Yamamoto N; Sasaki Y
J Neurochem; 2002 Apr; 81(1):9-16. PubMed ID: 12067241
[TBL] [Abstract][Full Text] [Related]
3. Rho-associated kinase phosphorylates MARCKS in human neuronal cells.
Nagumo H; Ikenoya M; Sakurada K; Furuya K; Ikuhara T; Hiraoka H; Sasaki Y
Biochem Biophys Res Commun; 2001 Jan; 280(3):605-9. PubMed ID: 11162562
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS).
Tatsumi S; Mabuchi T; Katano T; Matsumura S; Abe T; Hidaka H; Suzuki M; Sasaki Y; Minami T; Ito S
Neuroscience; 2005; 131(2):491-8. PubMed ID: 15708490
[TBL] [Abstract][Full Text] [Related]
5. New aspects of neurotransmitter release and exocytosis: Rho-kinase-dependent myristoylated alanine-rich C-kinase substrate phosphorylation and regulation of neurofilament structure in neuronal cells.
Sasaki Y
J Pharmacol Sci; 2003 Sep; 93(1):35-40. PubMed ID: 14501149
[TBL] [Abstract][Full Text] [Related]
6. Development of specific Rho-kinase inhibitors and their clinical application.
Tamura M; Nakao H; Yoshizaki H; Shiratsuchi M; Shigyo H; Yamada H; Ozawa T; Totsuka J; Hidaka H
Biochim Biophys Acta; 2005 Dec; 1754(1-2):245-52. PubMed ID: 16213195
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells.
Nagumo H; Sasaki Y; Ono Y; Okamoto H; Seto M; Takuwa Y
Am J Physiol Cell Physiol; 2000 Jan; 278(1):C57-65. PubMed ID: 10644512
[TBL] [Abstract][Full Text] [Related]
8. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: relevance to subarachnoid hemorrhage and vasospasm.
Wickman G; Lan C; Vollrath B
Circ Res; 2003 Apr; 92(7):809-16. PubMed ID: 12637369
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of protein kinase C-mediated contraction by Rho kinase inhibitor fasudil in rabbit aorta.
Shimomura E; Shiraishi M; Iwanaga T; Seto M; Sasaki Y; Ikeda M; Ito K
Naunyn Schmiedebergs Arch Pharmacol; 2004 Nov; 370(5):414-22. PubMed ID: 15459803
[TBL] [Abstract][Full Text] [Related]
10. Evidence for protein kinase C-mediated activation of Rho-kinase in a porcine model of coronary artery spasm.
Kandabashi T; Shimokawa H; Miyata K; Kunihiro I; Eto Y; Morishige K; Matsumoto Y; Obara K; Nakayama K; Takahashi S; Takeshita A
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2209-14. PubMed ID: 14592852
[TBL] [Abstract][Full Text] [Related]
11. Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathway.
Li J; O'Connor KL; Greeley GH; Blackshear PJ; Townsend CM; Evers BM
J Biol Chem; 2005 Mar; 280(9):8351-7. PubMed ID: 15623535
[TBL] [Abstract][Full Text] [Related]
12. The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro.
Tura A; Grisanti S; Petermeier K; Henke-Fahle S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2152-61. PubMed ID: 17460274
[TBL] [Abstract][Full Text] [Related]
13. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases.
Shimokawa H
J Cardiovasc Pharmacol; 2002 Mar; 39(3):319-27. PubMed ID: 11862109
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors.
Amobi NI; Chung IP; Smith IC
Auton Autacoid Pharmacol; 2006 Apr; 26(2):169-81. PubMed ID: 16553645
[TBL] [Abstract][Full Text] [Related]
15. Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries.
Kandabashi T; Shimokawa H; Mukai Y; Matoba T; Kunihiro I; Morikawa K; Ito M; Takahashi S; Kaibuchi K; Takeshita A
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):243-8. PubMed ID: 11834523
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
17. Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the rat penis.
Teixeira CE; Ying Z; Webb RC
J Pharmacol Exp Ther; 2005 Oct; 315(1):155-62. PubMed ID: 15976017
[TBL] [Abstract][Full Text] [Related]
18. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms.
Matsumoto Y; Uwatoku T; Oi K; Abe K; Hattori T; Morishige K; Eto Y; Fukumoto Y; Nakamura K; Shibata Y; Matsuda T; Takeshita A; Shimokawa H
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):181-6. PubMed ID: 14592842
[TBL] [Abstract][Full Text] [Related]
19. Essential role of rho kinase in the Ca2+ sensitization of prostaglandin F(2alpha)-induced contraction of rabbit aortae.
Ito K; Shimomura E; Iwanaga T; Shiraishi M; Shindo K; Nakamura J; Nagumo H; Seto M; Sasaki Y; Takuwa Y
J Physiol; 2003 Feb; 546(Pt 3):823-36. PubMed ID: 12563007
[TBL] [Abstract][Full Text] [Related]
20. HA1077, a protein kinase inhibitor, inhibits calponin phosphorylation on Ser175 in porcine coronary artery.
Nagumo H; Seto M; Sakurada K; Walsh MP; Sasaki Y
Eur J Pharmacol; 1998 Nov; 360(2-3):257-64. PubMed ID: 9851593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
